Prostatype Genomics AB today publishes its year-end report for the full year 2025, including the interim report for the second half of 2025. The full year-end report is attached and can also be downlo ...
Discover how the UAE is leading the way in precision medicine, offering hope to rare disease patients through advanced ...
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering: San Diego Saturday, March 7, 2026, 10:00 Hrs [IST] Illumina, Inc ...
Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing ...
O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've got a lot of work," said Major.
Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.
In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial ...
High‑frequency brain stimulation that synchronizes frontal–parietal activity led people to choose more generously, suggesting that altruism depends on rapid neural coordination.
Opportunities in the Abrysvo market are driven by unmet RSV vaccine needs, aging populations, rising RSV cases, and expanded adult immunization programs. Growth is supported by enhanced vaccine access ...
Researchers work in a mobile Fire-Eye laboratory in Beijing in June 2020. The labs can identify coronavirus infections, as well as decipher and analyze human DNA. (Fu ...
This project has been funded with federal funds under Contract No. HHSN263201800029I (75N98021F00009) between the National Academy of Sciences and the Department of Health and Human Services, National ...
Seasoned GovTech executive joins BlueGenAI as it builds the first Government Modernization Automation Platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results